ACTRN12624000438550招募中Unknown
The effectiveness of continuous Glucose Monitors plus kaiawhina-based care on glycemic control and cardiovascular outcomes in patients with Type 2 Diabetes in New Zealand
niversity of Waikato0 个研究点目标入组 90 人开始时间: 2024年4月10日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Inclusion: confirmed diagnosis of T2D for at least 1 year, HbA1c greater than or equal to 80mmol/mol (minimum two readings in 12 months prior to study), and prioritisation for Maori or Pacific ethnicity
排除标准
- •Exclusion: pregnancy, previous bariatric surgery, glucocorticoid use, severe diabetic eye disease, and/or history of any previous cardiovascular events or diagnosis with renal failure
研究者
相似试验
尚未招募
不适用
ECSPECT-HYPO trialNL-OMON29063Vrije Universiteit Medical Center115
已完成
不适用
Effectiveness of Continuous Glucose Monitoring versus Stepped Care with HypoAware, a Web-Based PsychoEducational Intervention, and adding CGM as needed, in Adult Type 1 Diabetes with Impaired Hypoglycemia Awareness: ECSPECT-HYPO trialNL-OMON48870Vrije Universiteit Medisch Centrum124
已完成
不适用
Effectiveness of continuous glucose monitoring during diabetic pregnancydiabetes mellitusNL-OMON38017Academisch Medisch Centrum300
招募中
不适用
Glucose Monitoring Met Sensor.pregnancy, diabetes mellitusNL-OMON27866ZonMW300
已完成
不适用
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) TherapyType 1 Diabetes MellitusNCT01104142DexCom, Inc.120